FEDERICO
PULIDO ORTEGA
Profesor asociado
Hospital Regional Universitario de Málaga
Málaga, EspañaHospital Regional Universitario de Málaga-ko ikertzaileekin lankidetzan egindako argitalpenak (10)
2020
-
Virological outcome among HIV infected patients transferred from pediatric care to adult units in Madrid, Spain (1997–2017)
Scientific Reports, Vol. 10, Núm. 1
2019
2018
-
Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study
American Journal of Transplantation, Vol. 18, Núm. 10, pp. 2513-2522
2016
-
Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma
Hepatology, Vol. 63, Núm. 2, pp. 488-498
-
Liver Retransplantation in Patients with HIV-1 Infection: An International Multicenter Cohort Study
American Journal of Transplantation, Vol. 16, Núm. 2, pp. 679-687
2015
-
Renal safety of coformulated tenofovir/emtricitabine vs other nucleoside analogues in combination therapy in antiretroviral-naive patients aged 50 years or older in Spain: The TRIP study
HIV Clinical Trials, Vol. 16, Núm. 1, pp. 43-48
2014
-
Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2014)
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 32, Núm. 7, pp. 447-458
2013
-
Safety, efficacy, and persistence of emtricitabine/tenofovir versus other nucleoside analogues in naive subjects aged 50 years or older in Spain: The TRIP study
HIV Clinical Trials, Vol. 14, Núm. 5, pp. 204-215
2000
1999
-
A randomized study comparing instruments for measuring health-related quality of life in HIV-infected patients
AIDS, Vol. 13, Núm. 13, pp. 1727-1735